Beta Bionics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $100.3 | $65.1 | $12.0 | — |
| Operating income | -$71.7 | -$45.3 | -$35.9 | — |
| Net income | -$73.2 | -$54.8 | -$44.1 | — |
| Cash Flow Statement | ||||
| Free cash flow | -$56.2 | -$51.7 | -$32.8 | — |
Shares outstanding 44.6M · Free float 74.5%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.